Kimberly-Clark
KMB Nasdaq· Household Products
Last close · Oct 26, 2026
$109.63
KIRA · Stoqly’s AI analyst, in plain words
- Kimberly-Clark had $16.4B of revenue in fiscal 2025, down 2.1% on the year before. Over five years, revenue changed −3.0% a year on average.
- Its operating margin was 14.3%, down 1.8 pts: of every 100 in sales, about 14 is left after running the business.
- Kimberly-Clark made $2.0B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 0.1% a year.
- Free cash flow was $1.6B in fiscal 2025, 10.0% of revenue.
- Kimberly-Clark returned $1.8B to shareholders in fiscal 2025, 110% of free cash flow. The diluted share count fell 1.1%.
- Kimberly-Clark owes $6.5B more than it holds in cash, about 2.1 years of operating profit.
Market cap
$36.5B
P/E
18.6x
Revenue
$16.4B
Net income
$2.0B
Free cash flow
$1.6B
Operating margin
14.3%
Kimberly-Clark in 30 seconds · fiscal 2025
Are sales growing?
−2.1%
No. Sales fell 2.1% last year.
Does it make a profit?
12.3%
Yes. It keeps 12.3% of every sale as profit.
Does profit turn into cash?
10.0%
Partly. 10.0% of sales ends up as free cash.
Is debt under control?
2.1x
Keep an eye on it. Repaying its debt would take 2.1 years of operating profit.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
18.6x
One share costs 18.6 times its yearly profit per share. Typical for its sector: 24.7x.
What Kimberly-Clark does
Kimberly-Clark makes and sells everyday paper and personal care products, including Huggies diapers, Kleenex tissues, Scott and Cottonelle bathroom tissue, Kotex and Poise pads, and Depend underwear for adults. It sells in more than 175 countries and territories. It groups its products into five categories: baby and child care, adult care, feminine care, family care and professional. Household products go to supermarkets, mass merchandisers, drugstores, warehouse clubs and online stores. Products for professional use go through distributors and directly to businesses such as hotels, factories and food service operations. Its largest customer is Walmart. The company reports two segments by region: North America and International Personal Care. It says it has several major competitors, some larger and more diversified than itself. Two deals are pending.
Biggest risks, in its own words
- Higher prices for raw materials, energy and shipping that it cannot pass on to customers.
- Intense competition, and failing to keep up with how consumers shop or to market its products well.
- Growing reliance on a few big retailers and on new online sales channels.
- The pending Kenvue deal may not close, or may not bring the benefits expected.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 12, 2026
- Legal name
- KIMBERLY-CLARK CORPORATION
- CIK
- 0000055785
Kimberly-Clark · KMB
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $19.4B | $20.2B | $17.1B | $16.8B | $16.4B |
| Revenue growth | 1.6% | 3.8% | −15.0% | −2.0% | −2.1% |
| Gross margin | 30.8% | 30.8% | 36.6% | 37.4% | 36.0% |
| Operating margin | 13.2% | 13.3% | 11.2% | 16.1% | 14.3% |
| Net income | $1.8B | $1.9B | $1.8B | $2.5B | $2.0B |
| Net margin | 9.3% | 9.6% | 10.3% | 15.1% | 12.3% |
| Diluted EPS | $5.35 | $5.72 | $5.21 | $7.55 | $6.07 |
| Cash | |||||
| Cash from operations | $2.7B | $2.7B | $3.5B | $3.2B | $2.8B |
| Capital expenditure | $1.0B | $876M | $766M | $721M | $1.1B |
| Free cash flow | $1.7B | $1.9B | $2.8B | $2.5B | $1.6B |
| FCF margin | 8.9% | 9.2% | 16.2% | 15.0% | 10.0% |
| Dividends paid | $1.5B | $1.6B | $1.6B | $1.6B | $1.7B |
| Share buybacks | $400M | $100M | $225M | $1.0B | $141M |
| Share count change | −1.1% | −0.2% | 0.2% | −0.5% | −1.1% |
| Debt and strength | |||||
| Cash and short-term investments | $270M | $427M | $1.1B | $1.0B | $688M |
| Debt incl. finance leases | $8.6B | $8.4B | $8.0B | $7.4B | $7.2B |
| Shareholders' equity | $514M | $547M | $915M | $840M | $1.5B |
| Net debt / EBITDA | 2.5x | 2.3x | 2.6x | 1.8x | 2.1x |
| Current ratio | 0.8x | 0.8x | 0.8x | 0.8x | 0.8x |
| Interest coverage | 10.0x | 9.5x | 6.6x | 10.0x | 9.2x |
| Returns and quality | |||||
| Return on capital | 22.4% | 23.8% | 19.2% | 29.9% | 21.5% |
| Return on equity | — | — | — | 290.0% | 172.6% |
| Piotroski F-score | 6 | 8 | 6 | 8 | 6 |
| Altman Z'' | 2.0 | 2.0 | 1.9 | 2.4 | 2.2 |
Insiders bought, 12 months
$1.0M
1 insider
Insiders sold, 12 months
$1.0M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Kimberly-Clark · KMB
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Kimberly-Clark KMB | $36.5B | −2.1% | 14.3% | 10.0% | 21.5% | 18.6x | 6 |
| Colgate-Palmolive CL | $74.6B | 1.4% | 16.2% | 17.8% | 37.3% | 36.8x | 5 |
| Church & Dwight CHD | $25.1B | 1.6% | 17.4% | 17.6% | 14.6% | 33.8x | 6 |
| Reynolds Consumer Products REYN | $4.9B | 0.7% | — | 8.5% | 9.9% | 14.7x | 5 |
| Central Garden & Pet CENT | $2.8B | −2.2% | 8.0% | 9.3% | 9.7% | 16.8x | 8 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $109.63 a share, the company is worth $36.5B: 18.6 times its earnings of the last four quarters.
Kimberly-Clark grew sales faster than 1 of its 4 similar companies. Its P/E is higher than 2 of 4.
Source: SEC EDGAR XBRL filings (CIK 0000055785). Data updated October 9, 2026. For information only — not investment advice. Check the original filings before relying on any figure.